Syneos Health Acquires Synteract from Amulet Capital Partners

NAMSA Acquires Syntactx

January 5, 2021

Healthcare Services

NAMSA, a medical device–focused contract research organization (and portfolio company of ArchiMed), has acquired New York–based CRO Syntactx. The add-on purchase expands NAMSA’s clinical research, electronic data capture (EDC), core lab imaging, safety and cardiovascular regulatory consulting capabilities to better serve global medtech sponsors.

ACL Digital Acquires Symbiance

September 26, 2025

Healthcare Services

ACL Digital, an ALTEN Group company, has acquired Symbiance, a US-based contract research organization (CRO) that provides clinical data management, biostatistics, medical writing and pharmacovigilance services. The acquisition expands ACL Digital's life sciences capabilities by adding AI-driven clinical research, CRO and pharmacovigilance expertise to its digital transformation and engineering services.

Mitratech Acquires Syntrio from Inverness Graham

January 10, 2024

Software

Mitratech has acquired Syntrio, an ethics and compliance software and e-learning platform, from Philadelphia-based private equity firm Inverness Graham. The transaction expands Mitratech’s governance, risk & compliance (GRC) and HR technology portfolio; terms were not disclosed.

Symeres Acquires Oncolines

January 10, 2023

Healthcare Services

Symeres, the Netherlands-headquartered transatlantic CRO & CDMO backed by Keensight Capital, has acquired Oncolines, an Oss-based oncology-focused CRO that provides early biology services and cell-line profiling assays. The add-on expands Symeres' oncology and precision-medicine biology capabilities and brings Oncolines' ~20 employees into the Symeres platform (part of NTRC Holding), increasing the group's integrated drug-discovery offering and proforma revenues to over €100m.

Sygnature Discovery Acquires NuChem Sciences

August 1, 2023

Biotechnology

UK-based integrated drug discovery CRO Sygnature Discovery has acquired Montreal-headquartered NuChem Sciences, one of North America's largest discovery contract research organisations. The deal expands Sygnature's global footprint and capabilities in medicinal chemistry, DMPK, structural biology and in vitro/in vivo pharmacology, strengthening its position in the North American market.

Investcorp Acquires Sanos Group

December 14, 2020

Healthcare Services

Investcorp has acquired Sanos Group, a Denmark-based contract research organization (CRO) specialized in osteoarthritis clinical trials and site management. Investcorp said it will support Sanos' international expansion and growth into additional therapeutic areas and geographies, including expanding its research clinic network.